| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 5.33▲ | 5.33▲ | 5.33▲ | 5.13▲ | 5.14▲ |
| MA10 | 5.33▲ | 5.34▼ | 5.32▲ | 5.12▲ | 5.02▲ |
| MA20 | 5.32▲ | 5.31▲ | 5.15▲ | 5.17▲ | 5.56▼ |
| MA50 | 5.34▼ | 5.10▲ | 5.17▲ | 5.07▲ | 4.84▲ |
| MA100 | 5.32▲ | 5.17▲ | 5.05▲ | 5.69▼ | 3.28▲ |
| MA200 | 5.16▲ | 5.09▲ | 5.12▲ | 5.45▼ | 5.25▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.003▲ | -0.010▼ | 0.024▲ | 0.017▲ | -0.095▼ |
| RSI | 54.038▲ | 61.435▲ | 63.684▲ | 54.819▲ | 50.445▲ |
| STOCH | 59.504 | 32.203 | 59.698 | 57.087 | 41.878 |
| WILL %R | -16.667▲ | -55.172 | -29.091 | -23.256▲ | -70.946 |
| CCI | 45.974 | -26.950 | 54.201 | 123.007▲ | 11.479 |
|
Sunday, March 22, 2026 08:34 PM
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at media & entertainment stocks, starting ...
|
|
Friday, March 20, 2026 04:49 PM
Immuneering Corp. operates as a clinical-stage oncology company, which engages in developing medicines for cancer patients. Its pipeline of drug candidates focuses on treating aspects of disease that ...
|
|
Tuesday, March 17, 2026 01:35 PM
Immuneering will present an analysis of circulating tumor DNA (ctDNA) from ≥64 patients with RAS-mutant solid tumors treated with atebimetinib, showing that acquired MAPK pathway alterations are ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 01/04/26 | 5.32 | 5.525 | 5.2481 | 5.33 | 532,201 |
| 31/03/26 | 4.96 | 5.275 | 4.93 | 5.27 | 545,396 |
| 30/03/26 | 4.99 | 5.06 | 4.85 | 4.88 | 581,097 |
| 27/03/26 | 5.18 | 5.2057 | 4.93 | 4.96 | 453,849 |
| 26/03/26 | 5.27 | 5.53 | 5.185 | 5.22 | 458,350 |
| 25/03/26 | 5.28 | 5.50 | 5.27 | 5.32 | 545,526 |
| 24/03/26 | 5.06 | 5.27 | 4.9921 | 5.23 | 582,821 |
| 23/03/26 | 5.02 | 5.165 | 4.80 | 5.12 | 709,897 |
| 20/03/26 | 4.81 | 5.03 | 4.755 | 5.02 | 7,292,770 |
| 19/03/26 | 4.70 | 4.91 | 4.67 | 4.86 | 1,108,681 |
|
|
||||
|
|
||||
|
|